Activity of MSI-78, h-Lf1-11 and cecropin B antimicrobial peptides alone and in combination with voriconazole and amphotericin B against clinical isolates of Fusarium solani - 29/05/21
, Carla Weiblen, Lara Baccarin Ianiski, Paula Cristina Stibbe, Janio Morais SanturioBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Fusarium infections have been associated with high mortality rates due to the lack of definition of an ideal treatment strategy. Antimicrobial peptides (AMPs) have potential antifungal activity. Therefore, investigating the in vitro activity of these molecules alone and in association with conventional antifungals against clinical isolates of Fusarium was the aim of this study. Fusarium solani (n=10) strains were tested against the AMPs, MSI-78, h-Lf1-11 and cecropin B in accordance with CLSI protocol. Further, a checkerboard assay for its combination with amphotericin B or voriconazole, was carried out. MSI-78, h-Lf1-11 and cecropin B exhibited antifungal activity against F. solani strains tested with MICs ranging from 20 to 320mg/L. Satisfactory percentage of synergism was demonstrated for all evaluated combinations, ranging from 70 to 100%. The use of AMPs combined with amphotericin B and voriconazole antifungals has great synergistic potential and deserve to be evaluated in murine models of fusariosis.
Le texte complet de cet article est disponible en PDF.Keywords : Fusarium solani, Antimicrobial peptides, MSI-78, h-Lf1-11, Cecropin B
Plan
Vol 31 - N° 2
Article 101119- juin 2021 Retour au numéro
Article précédent
- Essential oils and their components in combating fungal pathogens of animal and human skin
- Alicja Michalczyk, Paulina Ostrowska
- Physiological characterization and molecular identification of some rare yeast species causing onychomycosis
- Alexandra M. Montoya, Carolina E. Luna-Rodríguez, Alexandro Bonifaz, Rogelio de J. Treviño-Rangel, Olga C. Rojas, Gloria M. González
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?